Moscow Laboratory Group Gemotest Expands Cooperation with iSOFT

iSOFT Group LimitediSOFT Group Limited announces - The Gemotest group, one of the five biggest providers of laboratory diagnostic services in Moscow, expands its central laboratory network by integrating the iSOFT Laboratory Module for microbiology. After the successful implementation of the iSOFT laboratory information system in 2008 the diagnostics provider now wants to further expand its service profile in order to continue the set growth strategy in the future. The further development of the cooperation enables iSOFT to step forward into the Russian healthcare market and successfully widen its footprint in Eastern Europe.

Within this new project Gemotest will install the new iSOFT Laboratory microbiology module in the overarching network in its central laboratory in Moscow. In combination with the existing iSOFT Laboratory components the results of microbiological analysis will be integrated reliably into the workflow. This enables Gemotest to extend its services for special laboratory diagnostic examinations. Moreover, the high flexibility and scalability of the entire laboratory system allows for the implementation of additional 10 analytical devices into the IT environment of the laboratory group as well as the smooth set up of further working stations.

By this diversification Gemotest intends to increase its competitive position and win further market shares in the field of special laboratory diagnostic examinations. This aspect is an essential building block for the growth plans of the Russian diagnostics service provider.

"With Gemotest we found a partner in the Russian market, who already successfully implements modern IT systems for the management of workflow processes," said Peter Herrmann, Managing Director, iSOFT Health. "The Russian healthcare market with a total volume of approximately two billion U.S. Dollars and constant growth rates in the last few years is a key market for iSOFT. That's why it is particularly important to have strong regional partners and reference sites, who can serve as "Proof of Concept" for further potential customers."

The order allows Gemotest the implementation of a comprehensive laboratory infrastructure, which provides the necessary scalability to integrate additional devices and locations into the existing IT environment. To take advantage of this flexibility and scalability, Gemotest invested a total of approximately €100.000 in the expansion of the laboratory IT system as well as for support and system maintenance over five years.

Related news articles:

About Gemotest
The Moscow-based laboratory group Gemotest has entrusted more than 100 employees with the provision of diagnostic services. Every day up to 11,000 samples are analyzed and processed. The company, which for years pursued clear growth strategy, plans in the next years to establish other laboratory facilities in Russia and is one of the fastest-growing laboratory service providers in the country.

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 locations worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...